The Gene and Cell Therapy Lab (GCTL) provides translational researchers with the infrastructure, training and technical expertise necessary to develop and manufacture gene modified cells, vector production and ex-vivo manipulation of cells for novel gene and cell therapy products. We facilitate bench -to- bedside translation of gene and cellular therapy research such as immunotherapy and stem cell therapy. We provide both manufacturing and regulatory support needed by clinical research investigators to navigate the challenges of Phase I/II clinical trials. To ensure patient safety and compliance with current Good Manufacturing Practices, we operate under a comprehensive Quality Assurance program. How researches use this resource The GCTL has manufactured clinical cell products for a number of diverse investigator INDs.